Literature DB >> 33603020

An in vitro study on factors affecting endotoxin neutralization in human plasma using the Limulus amebocyte lysate test.

Stephan Harm1, Claudia Schildböck2, Karin Strobl2, Jens Hartmann2.   

Abstract

Endotoxin neutralization, caused by plasma components, makes it difficult to detect endotoxins in human blood. In this study, we investigated which factors influence the recovery of endotoxins using limulus ameobocyte lysate (LAL)-based assays. The individual factors that were examined in more detail were lipoprotein content, type of blood anticoagulation, kinetics and serum levels of divalent cations. Furthermore, it was investigated whether there is a direct correlation between LAL activity and monocyte activation. We could show that polyanionic heparin increases endotoxin recovery in blood, while citrate anticoagulation promotes endotoxin neutralization. Furthermore, we could show that the endotoxin activity in human plasma and serum decreases strongly over time. Time-dependent endotoxin neutralization reaches its maximum after 4-6 h incubation. By means of filtration tests we could determine that endotoxins in the plasma bind to lipoproteins but do not influence their activity. Comparative measurements have shown that high LAL activity of endotoxins in plasma simultaneously possesses high monocyte activating properties in whole blood. For the maximum recovery of endotoxins in human blood the physiological calcium and magnesium concentrations are sufficient. In this study, it was shown that the endotoxin neutralizing plasma components have a molecular weight similar to β2-microglobulin (11.7 kDa). For the exact identification of the endotoxin neutralizing plasma components, which caused a modulation of the immunostimulating endotoxin activity, further investigations have to be carried out in the future.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33603020      PMCID: PMC7893160          DOI: 10.1038/s41598-021-83487-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  59 in total

1.  Optimization of detection of bacterial endotoxin in plasma with the Limulus test.

Authors:  R I Roth; F C Levin; J Levin
Journal:  J Lab Clin Med       Date:  1990-08

2.  Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

Authors:  Helen M Colhoun; James D Otvos; Mike B Rubens; M R Taskinen; S Richard Underwood; John H Fuller
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

3.  Biological properties of structurally related alpha-helical cationic antimicrobial peptides.

Authors:  M G Scott; H Yan; R E Hancock
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Endotoxin: physical requirements for cell activation.

Authors:  M Mueller; B Lindner; R Dedrick; A B Schromm; U Seydel
Journal:  J Endotoxin Res       Date:  2005

5.  Antiendotoxin activity of cationic peptide antimicrobial agents.

Authors:  M Gough; R E Hancock; N M Kelly
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

Review 6.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.

Authors:  G W Cockerill; K A Rye; J R Gamble; M A Vadas; P J Barter
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311

8.  High-density lipoprotein prevents organ damage in endotoxemia.

Authors:  Ru-Ping Lee; Nien-Tsung Lin; Yann-Fen Chiou Chao; Chia-Chin Lin; Horng-Jyh Harn; Hsing-I Chen
Journal:  Res Nurs Health       Date:  2007-06       Impact factor: 2.228

9.  Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: role of defective triglyceride removal.

Authors:  C A Rouzer; A Cerami
Journal:  Mol Biochem Parasitol       Date:  1980-10       Impact factor: 1.759

10.  Capture of lipopolysaccharide (endotoxin) by the blood clot: a comparative study.

Authors:  Margaret T Armstrong; Frederick R Rickles; Peter B Armstrong
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more
  2 in total

1.  Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients.

Authors:  Seth G Thacker; Cheng Her; Logan Kelley-Baker; Derek D C Ireland; Mohanraj Manangeeswaran; Eric S Pang; Daniela Verthelyi
Journal:  Front Immunol       Date:  2022-09-06       Impact factor: 8.786

2.  Validation of Two Kinetic Assays for the Quantification of Endotoxin in Human Serum.

Authors:  Christian Barro; Anu Paul; Fermisk Saleh; Tanuja Chitnis; Howard L Weiner
Journal:  Front Neurol       Date:  2021-06-25       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.